Log in
NASDAQ:LJPC

La Jolla Pharmaceutical Earnings Date, Estimates & History

$3.90
+0.07 (+1.83 %)
(As of 09/25/2020 12:00 AM ET)
Add
Compare
Today's Range
$3.77
Now: $3.90
$3.94
50-Day Range
$3.54
MA: $4.05
$5.02
52-Week Range
$2.30
Now: $3.90
$9.71
Volume317,199 shs
Average Volume791,449 shs
Market Capitalization$106.71 million
P/E RatioN/A
Dividend YieldN/A
Beta2.6

Earnings

La Jolla Pharmaceutical (NASDAQ:LJPC) Earnings Information

La Jolla Pharmaceutical last released its quarterly earnings data on August 6th, 2020. The biopharmaceutical company reported ($0.57) EPS for the quarter, missing analysts' consensus estimates of ($0.44) by $0.13. The business earned $5.81 million during the quarter. La Jolla Pharmaceutical has generated ($4.30) earnings per share over the last year. La Jolla Pharmaceutical has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 10th, 2020 based off prior year's report dates.

La Jolla Pharmaceutical Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

La Jolla Pharmaceutical (NASDAQ:LJPC) Earnings Estimates

2020 EPS Consensus Estimate: ($2.45)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20201($0.77)($0.77)($0.77)
Q2 20201($0.74)($0.74)($0.74)
Q3 20201($0.50)($0.50)($0.50)
Q4 20201($0.44)($0.44)($0.44)

La Jolla Pharmaceutical (NASDAQ LJPC) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
11/10/2020
(Estimated)
       
8/6/20206/30/2020($0.44)($0.57)($0.57)$5.81 millionN/A
5/4/20203/31/2020($0.92)($0.32)($0.32)$8.50 million$7.59 millionN/A
3/2/202012/31/2019($0.95)($0.93)($0.93)$7.21 million$7.25 millionN/A
11/12/2019Q3 2019($1.05)($1.08)($1.08)$6.96 million$5.71 millionN/A
8/1/2019Q2 2019($1.1150)($1.1220)($1.12)$5.76 million$5.70 millionN/A
5/6/2019Q1($1.3130)($1.17)($1.17)$4.98 million$4.40 millionN/A
3/4/2019Q4($1.74)($1.73)($1.73)$4.20 million$4.18 millionTranscript
10/24/20189/30/2018($2.01)($1.93)($1.93)$3.38 million$3.47 millionN/A
8/8/2018Q2($1.95)($2.02)($2.02)$2.48 million$1.59 millionN/A
5/10/2018Q1 2018($1.4820)($2.2220)($2.22)$0.81 millionN/A
2/22/2018Q4 2017($1.25)($1.74)($1.74)N/A
10/26/2017Q3 2017($1.2420)($1.19)($1.19)N/A
7/27/2017Q2 2017($1.1250)($1.21)($1.21)$0.03 millionN/A
4/27/2017Q1 2017($1.3420)($1.26)($1.26)$0.17 millionN/A
2/23/2017Q4 2016($1.20)($1.44)($1.44)$0.16 million$0.09 millionN/A
11/3/2016Q3($0.97)($1.23)($1.23)$0.26 million$0.04 millionN/A
8/8/2016Q2($0.99)($0.90)($0.90)$0.25 million$0.25 millionN/A
5/6/2016Q416($0.74)($0.96)($0.96)$0.43 million$0.23 millionN/A
2/25/2016Q4($0.7170)($0.69)($0.69)$0.41 millionN/A
11/6/2015Q315($0.69)($0.70)($0.70)$0.65 millionN/A
8/7/2015Q215($0.61)($0.70)($0.70)N/A
4/29/2015Q1 2015($0.50)($0.59)($0.59)N/A
3/16/2015Q414($0.37)($0.45)($0.45)N/A
11/12/2014Q314($0.42)($0.37)($0.37)N/A
8/14/2014Q214($0.69)($0.63)($0.63)N/A
4/30/2014Q1 2014($0.91)($0.93)($0.93)N/A
3/31/2014Q4 2013($0.20)($72.74)($72.74)N/A
11/8/2013Q3 2013($5.50)($5.50)N/A
7/19/2013Q2 2013($7.00)($7.00)N/A
5/13/2013Q1 2013($12.50)($12.50)N/A
4/1/2013Q4 2012($14.00)($15.00)N/A
11/9/2012Q3 2012($450.00)($450.00)N/A
8/10/2012Q2 2012($33.50)($33.50)N/A
3/30/2012Q4 2011($593.80)$396.15N/A
8/17/2009Q2 2009($15,500.00)($15,500.00)N/A
10/31/2008Q3 2008($150,000.00)($155,000.00)($155,000.00)N/A
8/4/2008Q2 2008($175,000.00)($155,000.00)($155,000.00)N/A
5/1/2008Q1 2008($180,000.00)($172,000.00)($172,000.00)N/A
2/28/2008Q4 2007($180,000.00)($182,000.00)($182,000.00)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 9/26/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.